Rekvina Laboratories Announces Board Meeting to Approve Quarter Ended June 30, 2026 Financial Results
Rekvina Laboratories Ltd has scheduled a meeting of its Board of Directors to review and approve the Un-Audited Standalone Financial Results for the quarter ended on June 30, 2026. The board meeting is set to take place on August 13, 2026.The primary agenda item for the Board of Directors includes considering and approving the financial results under Indian Accounting Standards (Ind AS). Other necessary agendas will also be considered with the permission of the chair.
In alignment with its Code of Conduct for the Prevention of Insider Trading, the company has closed the trading window for its equity shares for designated persons. The closure period commenced on July 01, 2026, and will remain in effect until 48 hours following the publication of the said financial results.
Stock Price Movement
Rekvina Laboratories Ltd shares settled at ₹25.00 on Friday, slipping by 0.99% in the session. The equity traded completely flat, as both the high and low were locked at ₹25.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.